$12 billion AI startup founder says future tech giants could operate with under 100 employees

Company Insights - OpenEvidence, an AI-powered medical information and clinical decision support company, recently closed a $250 million Series D funding round, doubling its valuation to approximately $12 billion [2] - The company operates with fewer than 100 employees, yet its technology is expected to assist 300 million Americans in receiving medical treatment this year [3] - The CEO of OpenEvidence, Daniel Nadler, emphasizes that the scale of impact from small teams utilizing AI is unprecedented, suggesting a shift in how companies can be structured and operated [4] Industry Trends - There is a growing consensus among tech leaders that smaller teams can achieve results previously requiring larger organizations, driven by AI as a collaborative tool [4] - Block, a fintech company, announced a 40% reduction in its workforce due to AI efficiencies, indicating a broader trend of workforce restructuring in response to technological advancements [4] - McKinsey's research suggests that to fully leverage AI, organizations must undergo a double transformation—both technical and organizational—redefining workflows and employee roles [4][5] Market Dynamics - According to Capgemini's World Corporate and Investment Banking Report 2026, corporate and investment banks (CIBs) face increasing competition from non-bank financial institutions, with 85% of corporate banking clients planning to engage with non-bank entities within the next year [11][12] - The report indicates that only 23% of CIB clients feel their needs for real-time responsiveness and innovative solutions are currently met, highlighting a significant gap in service delivery [12] - A forecasted compound annual growth rate of 5.4% for CIBs over the next five years reflects a decline from the previous rate of 6.5% between 2022 and 2024, suggesting a need for CIBs to adapt their business models [13]